scholarly article | Q13442814 |
P50 | author | Åke Hedhammar | Q38156959 |
Agneta Egenvall | Q89994638 | ||
P2093 | author name string | Henrik von Euler | |
Brenda N Bonnett | |||
Pekka Olson | |||
Patrik Ohagen | |||
P433 | issue | 1-2 | |
P921 | main subject | Sweden | Q34 |
P304 | page(s) | 109-127 | |
P577 | publication date | 2005-02-23 | |
P1433 | published in | Preventive Veterinary Medicine | Q15761719 |
P1476 | title | Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. | |
P478 | volume | 69 |
Q55379064 | 5-Azacytidine treatment induces demethylation of DAPK1 and MGMT genes and inhibits growth in canine mammary gland tumor cells. |
Q33845912 | A monograph proposing the use of canine mammary tumours as a model for the study of hereditary breast cancer susceptibility genes in humans |
Q37267560 | A retrospective study of pyometra at five RSPCA hospitals in the UK: 1728 cases from 2006 to 2011. |
Q24288900 | Approaches to canine health surveillance |
Q35925731 | Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival |
Q36857180 | Breed-predispositions to cancer in pedigree dogs. |
Q35587062 | Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN |
Q35005628 | Canine atopic dermatitis: validation of recorded diagnosis against practice records in 335 insured Swedish dogs |
Q55368630 | Canine mammary tumors as a model for human disease. |
Q37885436 | Canine mammary tumours, an overview |
Q36746944 | Comparison of non-coding RNAs in human and canine cancer |
Q28084851 | Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer |
Q39665544 | Current status of canine cancer registration - report from an international workshop |
Q51528964 | Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. |
Q37020475 | Effect of Ovariohysterectomy at the Time of Tumor Removal in Dogs with Mammary Carcinomas: A Randomized Controlled Trial |
Q46278669 | Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial |
Q34446882 | Effects of the missense mutations in canine BRCA2 on BRC repeat 3 functions and comparative analyses between canine and human BRC repeat 3 |
Q35620813 | Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem |
Q34218855 | Establishment of a PCR analysis method for canine BRCA2. |
Q28659531 | Estimated incidence rate and distribution of tumours in 4,653 cases of archival submissions derived from the Dutch golden retriever population |
Q33851045 | Estimating canine cancer incidence: findings from a population-based tumour registry in northwestern Italy |
Q56997887 | Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay |
Q60046564 | Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis |
Q46927026 | General assessment of copy number variation in normal and tumor tissues of the domestic dog (Canis lupus familiaris). |
Q51129375 | Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours. |
Q36012010 | Genome-Wide Analysis Identifies Germ-Line Risk Factors Associated with Canine Mammary Tumours. |
Q38635393 | Germline gene polymorphisms predisposing domestic mammals to carcinogenesis |
Q91968762 | Global gene expression profile in canine mammary carcinomas |
Q48054650 | Identification of genetic variation in 11 candidate genes of canine mammary tumour |
Q33880705 | Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma. |
Q33513750 | Insurance data for research in companion animals: benefits and limitations |
Q37899470 | International and collaborative strategies to enhance genetic health in purebred dogs |
Q33798619 | Leading the way: canine models of genomics and disease |
Q38659029 | Life course analysis of the impact of mammary cancer and pyometra on age-anchored life expectancy in female Rottweilers: Implications for envisioning ovary conservation as a strategy to promote healthy longevity in pet dogs |
Q57068042 | Lipoma in dogs under primary veterinary care in the UK: prevalence and breed associations |
Q57168404 | Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks |
Q28730686 | Man's best friend becomes biology's best in show: genome analyses in the domestic dog |
Q47633999 | MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours |
Q45018163 | Mitochondrial D-loop mutations and polymorphisms are connected with canine malignant cancers. |
Q48037396 | Mitochondrial DNA polymorphism in genes encoding ND1, COI and CYTB in canine malignant cancers. |
Q37819443 | Molecular biological aspects on canine and human mammary tumors |
Q42601962 | Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours. |
Q35110632 | Mortality in over 350,000 insured Swedish dogs from 1995-2000: I. Breed-, gender-, age- and cause-specific rates |
Q21202822 | Mortality in over 350,000 insured Swedish dogs from 1995-2000: II. Breed-specific age and survival patterns and relative risk for causes of death |
Q58563203 | Multiplexed Autoantibody Signature for Serological Detection of Canine Mammary Tumours |
Q59126644 | Neuter status as a risk factor for canine intervertebral disc herniation (IVDH) in dachshunds: a retrospective cohort study |
Q21133689 | Neutering dogs: effects on joint disorders and cancers in golden retrievers |
Q64996512 | Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors. |
Q80844510 | Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot study |
Q33855456 | Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studies |
Q91739070 | Prognostic phenotypic classification for canine mammary tumors |
Q34333126 | Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker |
Q91587636 | Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas |
Q37151836 | RETRACTED: Diagnosis, classification and grading of canine mammary tumours as a model to study human breast cancer: an Clinico-Cytohistopathological study with environmental factors influencing public health and medicine |
Q35706967 | Reduced canine BRCA2 expression levels in mammary gland tumors |
Q33643473 | Retrospective study and immunohistochemical analysis of canine mammary sarcomas. |
Q38835774 | Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours |
Q90149784 | Surface plasmon resonance immunosensor for label-free detection of BIRC5 biomarker in spontaneously occurring canine mammary tumours |
Q34662587 | The ESR1 gene is associated with risk for canine mammary tumours |
Q34456885 | The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors |
Q41435545 | Tolerability and pharmacokinetic profile of a novel benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in dogs with malignant mammary tumours |
Q36071586 | What can cohort studies in the dog tell us? |
Search more.